Correlation Between Wesure Global and Nextage Therapeutics

Can any of the company-specific risk be diversified away by investing in both Wesure Global and Nextage Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wesure Global and Nextage Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Wesure Global Tech and Nextage Therapeutics, you can compare the effects of market volatilities on Wesure Global and Nextage Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wesure Global with a short position of Nextage Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wesure Global and Nextage Therapeutics.

Diversification Opportunities for Wesure Global and Nextage Therapeutics

0.72

Correlation Coefficient

Wesure Global  Nextage Therapeutics

Poor diversification

The 3 months correlation between Wesure and Nextage is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Wesure Global Tech and Nextage Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nextage Therapeutics and Wesure Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wesure Global Tech are associated (or correlated) with Nextage Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nextage Therapeutics has no effect on the direction of Wesure Global i.e., Wesure Global and Nextage Therapeutics go up and down completely randomly.

Pair Corralation between Wesure Global and Nextage Therapeutics

Assuming the 90 days trading horizon Wesure Global Tech is expected to under-perform the Nextage Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Wesure Global Tech is 1.63 times less risky than Nextage Therapeutics. The stock trades about -0.07 of its potential returns per unit of risk. The Nextage Therapeutics is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  7,550  in Nextage Therapeutics on October 10, 2024 and sell it today you would earn a total of  50.00  from holding Nextage Therapeutics or generate 0.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Wesure Global Tech  vs.  Nextage Therapeutics

Wesure Global Tech

Risk-Adjusted Performance

30 of 100

Very Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Wesure Global Tech are ranked lower than 30 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Wesure Global sustained solid returns over the last few months and may actually be approaching a breakup point.

Nextage Therapeutics

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Nextage Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Nextage Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Wesure Global and Nextage Therapeutics

The main advantage of trading using opposite Wesure Global and Nextage Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wesure Global position performs unexpectedly, Nextage Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextage Therapeutics will offset losses from the drop in Nextage Therapeutics' long position.

The idea behind Wesure Global Tech and Nextage Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.